Aesgp_Publications
Country_ProfilesOTC_IngredientWMSI_Publications

The market data 2007-2009 included in the tables below have been extracted from the AESGP study "Economic and Legal Framework for Non-Prescription Medicines", June 2010 edition. Data are reported at public price level, i.e. including wholesale and retail margins and Value Added Tax. For those countries reporting market data at other than public price level, the data have been adjusted to public price level according to best estimates.

Note: Some unusual fluctuations in non-euro countries may be due to exchange rate effects.

European pharmaceutical market – 2007-2009
(excluding hospital sales)
At consumer price level (euro millions)

€ millions

2007

2008

2009

Austria

3995

4292

4104

Belgium

4261

4484

4574

Bulgaria

596

680

789

Croatia

1516

1666

1625

Czech Republic

1695

1968

1588

Denmark

1707

1762

1753

Finland

2509

2653

2686

France

31000

30000

30150

Germany

36600

37370

37840

Greece

7979

8709

9549

Hungary

1973

2095

1950

Ireland

2068

2248

2333

Italy

19056

18872

19416

Netherlands

5758

5737

5730

Norway

2108

2092

2080

Poland

6321

7439

6964

Portugal

3577

3614

3583

Romania

1974

2135

2180

Russian Federation

9190

11570

10480

Slovak Republic

745

922

971

Slovenia

630

675

706

Spain

14032

16056

16588

Sweden

3968

3940

3647

Switzerland

3467

3727

4015

United Kingdom

26617

23653

20882

EU-27

179168

181396

180063

Europe

193340

198359

196183

Source: AESGP and AESGP National Associations 2010©

Total pharmaceutical market: sales of all medicinal products (excluding hospital sales) at public price level, including Value Added Tax (VAT).


 

European non-prescription pharmaceutical market 2007-2009

At consumer price level (euro millions)

As a percentage of the total pharmaceutical market
(excluding hospital sales)

€ millions

2007

2008

2009

Austria

339

348

343

Belgium

665

676

703

Bulgaria

158

192

203

Croatia

165

177

171

Czech Republic

437

529

515

Denmark

223

227

240

Finland

273

296

285

France

5921

5500

5560

Germany

5869

5680

5300

Greece

297

319

337

Hungary

273

315

309

Ireland

330

360

369

Italy

2145

2160

2201

Netherlands

696

701

725

Norway

253

261

259

Poland

1702

1997

1798

Portugal

226

229

233

Romania

458

477

453

Russian Federation

3130

3650

3840

Slovak Republic

171

231

251

Slovenia

50

56

64

Spain

1145

1747

1767

Sweden

367

371

355

Switzerland

827

881

952

United Kingdom

4608

4094

3777

EU-27

26618

26767

26046

Europe

30740

31475

31010

%

2007

2008

2009

8.5%

8.1%

8.4%

15.6%

15.1%

15.4%

26.5%

28.2%

25.7%

10.9%

10.6%

10.5%

25.8%

26.9%

32.4%

13.1%

12.9%

13.7%

10.9%

11.2%

10.6%

19.1%

18.3%

18.4%

16.0%

15.2%

14.0%

3.7%

3.7%

3.5%

13.9%

15.0%

15.8%

16.0%

16.0%

15.8%

11.3%

11.4%

11.3%

12.1%

12.1%

12.6%

12.0%

12.5%

12.4%

26.9%

26.8%

25.8%

6.7%

6.3%

6.5%

23.2%

22.4%

20.8%

34.1%

31.5%

36.6%

23.0%

25.1%

25.8%

7.9%

8.3%

9.1%

8.2%

10.9%

10.7%

9.2%

9.4%

9.7%

23.9%

23.6%

23.7%

17.3%

17.3%

18.1%

14.9%

14.8%

14.5%

15.9%

15.9%

15.8%

Source: AESGP and AESGP National Associations 2010©

Non-prescription pharmaceutical market: sales of all medicinal products legally available without a medical prescription at public price level, including Value Added Tax (VAT).


European self-medication pharmaceutical market 2007-2009

At consumer price level (euro millions)

As a percentage of the total pharmaceutical market
(excluding hospital sales)

€ millions

2007

2008

2009

Austria

300

308

307

Belgium

665

676

703

Bulgaria

158

192

203

Croatia

165

177

171

Czech Republic

437

529

515

Denmark

223

227

240

Finland

273

296

285

France

1926

1978

1989

Germany

4497

4350

4230

Greece

297

319

337

Hungary

273

315

309

Ireland

315

333

339

Italy

1596

1597

1603

Netherlands

628

635

652

Norway

253

261

259

Poland

1702

1997

1798

Portugal

226

229

233

Romania

458

477

453

Russian Federation

3130

3650

3840

Slovak Republic

171

231

251

Slovenia

50

56

64

Spain

618

1744

1822

Sweden

367

371

355

Switzerland

566

602

651

United Kingdom

3334

2880

2649

EU-27

19099

20171

19775

Europe

22959

24600

24437

%

2007

2008

2009

7.5%

7.2%

7.5%

15.6%

15.1%

15.4%

26.5%

28.2%

25.7%

10.9%

10.6%

10.5%

25.8%

26.9%

32.4%

12.7%

13.0%

13.7%

10.9%

11.2%

10.6%

6.2%

6.6%

6.6%

12.3%

11.6%

11.2%

3.7%

3.7%

3.5%

13.9%

15.0%

15.8%

15.2%

14.8%

14.5%

8.4%

8.5%

8.3%

10.9%

11.0%

11.4%

12.0%

12.5%

12.4%

26.9%

26.8%

25.8%

6.7%

6.3%

6.5%

23.2%

22.4%

20.8%

34.1%

31.5%

36.6%

23.0%

25.1%

25.8%

7.9%

8.3%

9.1%

5.6%

10.9%

11.0%

9.2%

9.4%

9.7%

16.3%

16.2%

16.2%

12.5%

12.2%

12.7%

10.7%

11.1%

11.0%

11.9%

12.4%

12.5%

Source: AESGP and AESGP National Associations 2010©

Self-medication pharmaceutical market: all medicinal products bought spontaneously by consumers without a medical prescription at public price level, including Value Added Tax (VAT).


Self-medication product groups – 2007-2009

Cough & Cold

At consumer price level (euro millions)

€ millions

2007

2008

2009

Austria

103.0

110.4

117.4

Belgium

147.2

151.7

157.0

Bulgaria

39.0

46.0

50.0

Croatia

40.6

44.4

47.3

Czech Republic

100.4

124.7

122.7

Denmark

4.5

5.0

5.9

Finland

25.3

19.5

22.8

France

513.0

501.0

498.0

Germany

1083.0

1071.0

1103.0

Greece

69.7

76.3

89.5

Hungary

13.8

13.9

12.8

Ireland

51.2

54.7

56.2

Italy

644.0

650.0

687.0

Netherlands

121.5

123.5

131.4

Norway

30.8

30.6

29.4

Poland

358.2

414.7

407.5

Portugal

66.1

65.5

73.6

Romania

58.7

65.3

61.6

Russian Federation

782.0

956.0

996.0

Slovak Republic

40.0

56.9

66.6

Slovenia

14.4

16.5

19.0

Spain

342.0

387.0

391.0

Sweden

22.0

21.8

19.6

Switzerland

143.9

153.1

175.6

United Kingdom

638.1

568.9

490.7

EU-27

4485.9

4574.9

4612.7

Europe

5452.3

5728.4

5831.6

Source: AESGP and AESGP National Associations 2010©


Self-medication product groups – 2007-2009

Analgesics

At consumer price level (euro millions)

€ millions

2007

2008

2009

Austria

54.1

56.3

56.9

Belgium

125.8

129.9

140.3

Bulgaria

37.0

42.0

44.0

Croatia

28.6

29.2

33.8

Czech Republic

87.5

102.7

97.7

Denmark

45.0

45.2

45.6

Finland

80.0

75.8

114.7

France

351.0

356.0

366.0

Germany

456.0

438.0

423.0

Greece

71.4

76.4

80.9

Hungary

30.8

33.4

29.5

Ireland

71.3

79.5

82.4

Italy

409.0

426.0

451.0

Netherlands

136.6

129.4

131.0

Norway

38.2

41.9

47.7

Poland

245.0

414.7

308.9

Portugal

41.3

43.5

45.3

Romania

70.0

65.8

57.1

Russian Federation

348.0

428.0

407.0

Slovak Republic

27.7

39.4

40.9

Slovenia

9.4

11.0

12.5

Spain

246.0

264.0

243.0

Sweden

56.5

57.4

56.2

Switzerland

126.5

133.3

141.8

United Kingdom

770.5

676.9

608.3

EU-27

3459.8

3605.2

3482.9

Europe

3962.9

4195.7

4065.4

Source: AESGP and AESGP National Associations 2010©


Self-medication product groups – 2007-2009

Digestives

At consumer price level (euro millions)

€ millions

2007

2008

2009

Austria

41.0

43.6

50.1

Belgium

136.8

140.8

141.9

Bulgaria

12.0

16.0

17.0

Croatia

12.3

14.2

13.7

Czech Republic

44.5

56.4

57.0

Denmark

9.9

10.8

10.5

Finland

41.1

38.4

62.7

France

269.0

264.0

277.0

Germany

579.0

586.0

589.0

Greece

32.6

34.5

35.2

Hungary

33.0

36.1

35.0

Ireland

31.0

28.0

34.9

Italy

418.0

420.0

414.0

Netherlands

46.3

49.3

55.3

Norway

26.8

26.9

30.4

Poland

203.0

265.7

246.5

Portugal

31.5

32.9

37.7

Romania

8.5

8.7

8.1

Russian Federation

889.9

1049.0

1054.0

Slovak Republic

19.4

26.5

28.7

Slovenia

6.0

6.8

6.8

Spain

191.0

214.0

321.0

Sweden

30.3

32.7

36.0

Switzerland

44.2

47.4

46.4

United Kingdom

354.2

329.0

289.7

EU-27

2564.8

2667.0

2784.4

Europe

3510.3

3777.6

3898.5

Source: AESGP and AESGP National Associations 2010©


Self-medication product groups – 2007-2009

Skin products

At consumer price level (euro millions)

€ millions

2007

2008

2009

Austria

41.9

45.2

45.1

Belgium

55.1

55.0

57.2

Bulgaria

9.0

12.0

14.0

Croatia

6.1

8.5

8.1

Czech Republic

31.6

37.1

37.8

Denmark

9.9

9.9

10.6

Finland

32.7

30.2

44.5

France

187.0

184.0

186.0

Germany

385.0

374.0

380.0

Greece

57.9

58.8

61.3

Hungary

26.7

25.8

21.6

Ireland

36.6

38.3

45.7

Italy

182.0

193.0

202.0

Netherlands

57.4

60.3

67.8

Norway

16.3

17.6

17.1

Poland

117.5

147.9

147.9

Portugal

33.3

33.4

33.3

Romania

20.2

21.2

18.8

Russian Federation

305.0

375.0

353.0

Slovak Republic

12.1

17.1

19.2

Slovenia

6.0

5.5

5.6

Spain

116.0

129.0

133.0

Sweden

23.5

24.5

23.4

Switzerland

63.7

75.1

80.0

United Kingdom

618.1

527.6

466.1

EU-25

2075.7

2047.4

2038.1

Europe

2450.5

2506.0

2479.2

Source: AESGP and AESGP National Associations 2010©


Self-medication product groups – 2007-2009

Vitamins & Minerals

At consumer price level (euro millions)

€ millions

2007

2008

2009

Austria

69.6

74.1

75.3

Belgium

38.9

40.9

44.9

Bulgaria

18.0

21.0

21.0

Croatia

24.8

25.0

22.1

Czech Republic

74.1

80.6

71.4

Denmark

11.1

11.1

10.8

Finland

29.8

27.8

30.8

France

84.0

85.0

89.0

Germany

277.0

255.0

238.0

Greece

119.0

122.4

116.4

Hungary

52.8

54.8

53.1

Ireland

32.5

34.2

35.2

Italy

158.0

140.0

119.0

Netherlands

135.0

134.8

132.1

Norway

7.8

8.1

8.6

Poland

258.1

284.2

288.6

Portugal

13.6

13.6

7.3

Romania

37.8

59.3

50.0

Russian Federation

150.0

162.0

137.0

Slovak Republic

32.5

37.3

36.3

Slovenia

4.7

5.3

5.5

Spain

140.0

159.0

182.0

Sweden

56.5

51.9

43.8

Switzerland

50.5

57.0

59.9

United Kingdom

492.0

404.1

363.9

EU-27

2142.8

2104.6

2022.9

Europe

2368.1

2348.6

2241.9

Source: AESGP and AESGP National Associations 2010©

 

 
7 Avenue de Tervuren, B-1040 Brussels, Belgium | Tel: +32 (0)2 735 51 30 | Fax: +32 (0)2 735 52 22 | info@aesgp.be